BAY-85-8102

N/A

Report date: 2025/11/25 15:52:50
NME

Base Information

Drug NameBAY-85-8102
Drug Alias NameBAY-85-8102[18F]DPA-714
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionTranslocator protein ligands
TargetsTranslocator protein
Therapy Area/IndicationsNeuritisEpilepsy, Post-TraumaticParkinson Disease +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California DavisInstitut De Cancerologie De L OuestUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsNeuritisEpilepsy, Post-TraumaticParkinson Disease +[8] 
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A